|1.||Thunyakitpisal, Pasutha: 2 articles (05/2013 - 06/2010)|
|2.||Zou, Cun-Hua: 1 article (08/2015)|
|3.||Xiao, Yong: 1 article (08/2015)|
|4.||Song, Jiao: 1 article (08/2015)|
|5.||Qi, Jun-Hua: 1 article (08/2015)|
|6.||Li, Xiang-Yun: 1 article (08/2015)|
|7.||Dong, Chen-Hui: 1 article (08/2015)|
|8.||Li, Zhuang: 1 article (08/2015)|
|9.||Fu, Ting-Ting: 1 article (08/2015)|
|10.||Xing, Wei: 1 article (08/2015)|
|1.||Wounds and Injuries (Trauma)
08/01/2015 - "Acemannan promoted skin wound healing partly through activating AKT/mTOR-mediated protein translation mechanism, which may represent an alternative therapy approach for cutaneous wound."
08/01/2015 - "We found that acemannan significantly accelerated skin wound closure and cell proliferation. "
08/01/2015 - "Mouse skin wound model and skin primary fibroblasts were used to demonstrate the positive effect of acemannan on cutaneous wound healing. "
07/15/1995 - "Acemannan-containing wound dressing gel reduces radiation-induced skin reactions in C3H mice."
10/01/1998 - "To evaluate effectiveness of this treatment, 30 patients were randomized to receive either daily topical application of the hydrogel study dressing (acemannan hydrogel wound dressing) or a moist saline gauze dressing. "
|2.||Pressure Ulcer (Bedsore)
12/01/1991 - "Efficacy of acemannan in treatment of canine and feline spontaneous neoplasms."
09/01/1995 - "Following four to seven weekly acemannan treatments, tumor shrinkage occurred in four (greater than 50%; n = 2) of 12 animals, with tumors accessible to measurement. "
12/01/1991 - "Forty-three dogs and cats with spontaneous tumors were treated with the immunostimulating polysaccharide acemannan by intraperitoneal and intralesional routes of administration. "
06/01/1991 - "with acemannan at the time of tumor cell implantation were infiltrated by immune system cells, became necrotic, and regressed. "
06/01/1991 - "Approximately 40% of animals treated with acemannan at the time of tumor cell implantation (1.5 x 10(6) cells) survived. "
|4.||Dry Socket (Alveolar Osteitis)
06/01/2011 - "Within the limitations of the present study, it can be concluded that acemannan in the form of the SaliCept patch is an acceptable alternative to alvogyl as a dressing for the management of alveolar osteitis. "
04/01/2002 - "Reduction in the incidence of alveolar osteitis in patients treated with the SaliCept patch, containing Acemannan hydrogel."
|5.||Retroviridae Infections (Infection, Retrovirus)
|2.||spearmint oil drug combinations iodoform eugenol butyl aminobenzoate
|6.||Triamcinolone Acetonide (Azmacort)